Global Neurology DevicesMarket is
expected to reach USD 10.8 billion by 2022, according to a new report by Grand
View Research, Inc. This expected growth in demand can be ascribed to growing
need for development of different neurostimulation techniques with efficient
and accurate algorithms for treatment of several CNS associated disorders.
Rise
in incidence of cerebral stroke and other severe disorders such as Alzheimer’s
disease, epilepsy, and Parkinsonism is expected to fuel demand of neurology
devices thereby driving industry growth. According to National Institute of
Neurological Disorders and Stroke (NINDS), approximately 50 million Americans
are affected due to these disorders leading to high economic & disease
costs burden for medical expenses coupled with loss of productivity. The
industry is expected to witness a considerable increase in demand for CNS
related therapeutic procedures over the forecast period.
North America neurology devices market, by application, 2012 to 2022 (USD Million)
North America neurology devices market, by application, 2012 to 2022 (USD Million)
Browse
Details of Report @ http://www.grandviewresearch.com/industry-analysis/neurology-devices-market
Further key findings from the study suggest:
- Neurostimulation
devices accounted for over 50% of the revenue generated in the market for
2014. This large share can be attributed to the growing number of chronic
CNS disorders, a globally ageing population and development of minimally
invasive neurological and faster acting stimulation devices that attract
higher market usage and penetration in the neurology devices market.
- Neurosurgery
segment including ultrasonic aspirators, stereotactic systems, neuroendoscopes,
and aneurysm clips are expected to witness considerable growth over the
forecast period due to their essential nature of use in tumor removal and
brain cell damage repair surgeries.
- North
America dominated the market in 2014, with revenue estimated at over USD
2,400 million. Presence of sophisticated healthcare infrastructure,
favorable government initiatives pertaining to pharmaceutical R&D,
cancer research, neurological R&D investment, and the presence of a
considerably large CNS disorder patient base are some drivers of this
market.
- Asia Pacific
is expected to witness lucrative CAGR of over 8.0% from 2015 to 2022 due
to the presence of high-unmet medical needs coupled with rapidly rising
healthcare R&D investment, and growing medical expenditures in
emerging economies such as India and China. Supportive government
initiatives pertaining to increasing investments by manufacturers and
governments in neuro-informatics and high untapped market opportunities
are the important factors accounting for the expected growth of market in
this region over the forecast period.
- Key
participants of the neurology devices market include Johnson and Johnson,
B.Braun Melsungen AG, Boston Scientific Corporation, St. Jude Medical Inc
Covidien PLC, Medtronic Inc., Johnson & Johnson, Magstim Co Ltd., W.L.
Gore & Associates Inc., Integra Life Sciences Holdings Corp., Stryker
Corp.
- Market
participants are involved in R&D for development of advanced
stimulation and neuromodulation techniques with minimally invasive
procedures that are more preferable to the patients. Furthermore,
collaborations with university as well as non-university based institutes
that are engaged in neuroscience research are expected to boost sector
growth in the coming years.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment